The Tale of the Tape(Worm)

The Tale of the Tape(Worm)

In years gone by, I was required to dissect a tapeworm in high school biology. The fact that I vividly recall the tapeworm (after all these decades) attests to the gruesomeness of the task. A tapeworm is a parasite that sets up home in your digestive system, with the longest species able to grow to → Read More

A Conflicted Market

A Conflicted Market

I’m just not finding a lot to work with right now. Many stocks appear overbought, but are not offering the right setups for bearish trades. Straddles would be an ideal trade strategy, as they can benefit if the underlying continues rising, and especially if the underlying falls sharply. The problem with straddles right now is → Read More

Money Market Funds, The SEC, And Grandma (Part II)

Money Market Funds, The SEC, And Grandma (Part II)

In Part I, we reviewed the SEC’s journey toward reforming the regulatory framework of U.S. money-market funds in an attempt to proactively mitigate the financial risk that emerged when the Reserve Primary Fund “broke the buck” in 2008 and helped to “freeze” the nation’s short-term credit network. The situation was volatile enough to prompt the → Read More

Money Market Funds, The Sec, And Grandma (Part I)

Money Market Funds, The Sec, And Grandma (Part I)

Do you recall the tongue-in-cheek Christmas song classic: “Grandma Got Run Over By a Reindeer”? That is the image that sprang to mind last August when the then U.S. Securities and Exchange Commission (SEC) Chair, Mary Shapiro, tried to force through a new regulation that (among other things) would compel U.S. money-market funds to move → Read More

Volatility Up, Volume Spotty

Volatility Up, Volume Spotty

Most stocks show a nice reversal pattern countering the drop of the past three days. Many set what looks like higher short-term cycle lows. But everyone didn’t participate volume-wise. Yes, the summer vacation season is beginning and the Hamptons are beckoning. But reversals on weak volume at any time of the year are suspect. My → Read More

Time for War?

Time for War?

Forget the NSA scandal.  Forget Edward Snowden.  The focus has shifted now to war as the White House will seek to arm Syrian rebels following the claim that chemical weapons have been used against Syrian rebels.  Make no mistake about it, the agenda is to remove Assad (below); a major pipeline is at stake, and → Read More

Faster Than A Speeding Bullet

Faster Than A Speeding Bullet

Faster than a speeding bullet.  More powerful than a locomotive.  And able to leap tall buildings in a single bound. Is it a bird?  Is it a plane? No, it’s… Not superman. It’s this wild and crazy market. Above you see the treacherous fall into the close on Wednesday, followed by an equally, if not → Read More

Is Berkshire Prepared For A Stock Market Crash? (Part II)

Is Berkshire Prepared For A Stock Market Crash? (Part II)

In Part I, we shared a series of graphs based upon key financial data from the quarterly statements of Berkshire Hathaway (BRK-A). The objective of the study was to discern what indicators (if any) could be reliably utilized as useful tools regarding Buffett’s asset allocation and evaluation of “relative value” within the markets. In this → Read More

Does Buffett’s Balance Sheet Suggest a Market Top?

Does Buffett’s Balance Sheet Suggest a Market Top?

Just as children’s literature has provided us with “giants” (Paul Bunyan; the giant from “Jack and the Beanstalk”; etc.) so the investment world provides us with “giants” as well – persons whose names are intoned with a reverence reserved for precious few Wall Street figures. The identity of the currently “biggest” investment giant is debatable. → Read More

Dow Futures Down Over 100 Pre-Market

Dow Futures Down Over 100 Pre-Market

Bloomberg European 500 Index down 1.5% is hurting US futures pre-market, but it’s the close as always that matters. Courtesy of Bloomberg.com Other pre-market news: LuluLemon CEO “steps down”…. despite this 5-year performance (expect more revelations to come). Chart Courtesy of StockCharts.com Facebook’s shareholder meeting takes place today, expect volatility and beware of entering new → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.